We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Netflix
NFLX
$331B
| $227M | 0.43% |
1,697,590
-48,260
| -3% | -$5.46M |
|
52
Insulet
PODD
$9.86B
| $227M | 0.43% |
723,363
+90,494
| +14% | +$26.1M |
|
53
Enbridge
ENB
$109B
| $224M | 0.42% |
4,937,949
+85,688
| +2% | +$3.89M |
|
54
AT&T
T
$175B
| $220M | 0.41% |
7,605,264
-1,521,733
| -17% | -$41.9M |
|
55
TotalEnergies
TTE
$191B
| $220M | 0.41% |
3,582,127
+30,102
| +0.8% | +$1.79M |
|
56
Travelers Companies
TRV
$76.7B
| $216M | 0.41% |
806,535
+63,445
| +9% | +$16.7M |
|
57
Southern Company
SO
$102B
| $215M | 0.41% |
2,343,596
-702,697
| -23% | -$63.1M |
|
58
WEC Energy
WEC
$34.7B
| $212M | 0.4% |
2,030,461
+30,987
| +2% | +$3.3M |
|
59
Cencora
COR
$61.6B
| $206M | 0.39% |
688,656
+133,907
| +24% | +$38.6M |
|
60
Kimberly-Clark
KMB
$36.5B
| $204M | 0.38% |
1,583,193
+1,231,501
| +350% | +$167M |
|
61
Cheniere Energy
LNG
$57.1B
| $199M | 0.38% |
819,048
+57,225
| +8% | +$13.3M |
|
62
GE Aerospace
GE
$361B
| $199M | 0.37% |
772,208
+46,754
| +6% | +$10.3M |
|
63
Coca-Cola
KO
$385B
| $197M | 0.37% |
2,787,569
-1,757,475
| -39% | -$125M |
|
64
Five Below
FIVE
$14B
| $196M | 0.37% |
1,496,952
+10,971
| +0.7% | +$1.07M |
|
65
Boston Scientific
BSX
$68.5B
| $195M | 0.37% |
1,813,505
+18,665
| +1% | +$1.89M |
|
66
Kenvue
KVUE
$36.8B
| $193M | 0.36% |
9,220,268
+467,505
| +5% | +$10.6M |
|
67
Salesforce
CRM
$204B
| $189M | 0.36% |
694,543
+297,003
| +75% | +$79.4M |
|
68
Sanofi
SNY
$108B
| $188M | 0.35% |
3,887,629
-59,954
| -2% | -$3.06M |
|
69
Toast
TOST
$20.6B
| $178M | 0.34% |
4,024,942
+1,504,507
| +60% | +$59.1M |
|
70
Amcor
AMCR
$21.7B
| $177M | 0.33% |
3,858,268
+108,846
| +3% | +$5.02M |
|
71
Xcel Energy
XEL
$48.1B
| $177M | 0.33% |
2,599,729
+31,389
| +1% | +$2.18M |
|
72
Kimco Realty
KIM
$16B
| $176M | 0.33% |
8,369,774
+1,124,125
| +16% | +$23.3M |
|
73
Deckers Outdoor
DECK
$12B
| $176M | 0.33% |
1,705,634
+541,657
| +47% | +$60M |
|
74
Align Technology
ALGN
$11.4B
| $175M | 0.33% |
926,733
+219,219
| +31% | +$38.7M |
|
75
Applovin
APP
$105B
| $175M | 0.33% |
499,002
+88,977
| +22% | +$28.8M |
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.